134 related articles for article (PubMed ID: 2580121)
41. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
[TBL] [Abstract][Full Text] [Related]
42. Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins.
Vogel AM; Gown AM; Caughlan J; Haas JE; Beckwith JB
Lab Invest; 1984 Feb; 50(2):232-8. PubMed ID: 6198560
[TBL] [Abstract][Full Text] [Related]
43. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
[TBL] [Abstract][Full Text] [Related]
44. Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system.
Chaudhry A; Oberg K; Gobl A; Heldin CH; Funa K
Anticancer Res; 1994; 14(5B):2085-91. PubMed ID: 7840504
[TBL] [Abstract][Full Text] [Related]
45. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
46. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
47. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
Sökmensüer C; Gedikoglu G; Uzunalimoglu B
Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
[TBL] [Abstract][Full Text] [Related]
48. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors.
Leoncini P; Bellizzi de Marco E; Bugnoli M; Mencarelli C; Vindigni C; Cintorino M
Pathol Res Pract; 1989 Dec; 185(6):848-55. PubMed ID: 2482482
[TBL] [Abstract][Full Text] [Related]
49. Induction of cytokeratin expression in human mesenchymal cells.
von Koskull H; Virtanen I
J Cell Physiol; 1987 Nov; 133(2):321-9. PubMed ID: 2445764
[TBL] [Abstract][Full Text] [Related]
50. Bronchial carcinoids with S-100 positive sustentacular cells. A comparative study with gastrointestinal carcinoids, pheochromocytomas and paragangliomas.
Barbareschi M; Frigo B; Mosca L; Carboni N; Arrigoni GP; Leonardi E; Wilander E; Siegal GP; Shiro BC
Pathol Res Pract; 1990 Apr; 186(2):212-22. PubMed ID: 2188235
[TBL] [Abstract][Full Text] [Related]
51. Coexpression of cytokeratin, neurofilament and vimentin in carcinoid tumors.
Kimura N; Sasano N; Namiki T; Nakazato Y
Virchows Arch A Pathol Anat Histopathol; 1989; 415(1):69-77. PubMed ID: 2472033
[TBL] [Abstract][Full Text] [Related]
52. [Peptide-producing neoplasms in the gastrointestinal tract].
Schrumpf E; Gjone E
Tidsskr Nor Laegeforen; 1979 Mar; 99(9-10):465-6. PubMed ID: 220750
[No Abstract] [Full Text] [Related]
53. Variability of expression and arrangement of cytokeratin and neurofilaments in cutaneous neuroendocrine carcinomas (Merkel cell tumors): immunocytochemical and biochemical analysis of twelve cases.
Moll R; Osborn M; Hartschuh W; Moll I; Mahrle G; Weber K
Ultrastruct Pathol; 1986; 10(6):473-95. PubMed ID: 2435039
[TBL] [Abstract][Full Text] [Related]
54. Argentaffin and argyrophil reactions of human gastrointestinal carcinoids.
Wilander E; Portela-Gomes G; Grimelius L; Westermark P
Gastroenterology; 1977 Oct; 73(4 Pt 1):733-6. PubMed ID: 70388
[TBL] [Abstract][Full Text] [Related]
55. Zollinger-Ellison syndrome. Clinical and histopathologic manifestations.
Schulte WJ; Hensley G; Garancis JC; Wilson SD; Ellison EH
Am J Surg; 1969 Jun; 117(6):866-75. PubMed ID: 4307522
[No Abstract] [Full Text] [Related]
56. Cytokeratin expression in small intestinal and appendiceal carcinoids. A basis for classification.
Wilander E; Scheibenpflug L
Acta Oncol; 1993; 32(2):131-4. PubMed ID: 7686762
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and the 68-kD neurofilament protein.
Miettinen M; Rapola J
Am J Surg Pathol; 1989 Feb; 13(2):120-32. PubMed ID: 2464953
[TBL] [Abstract][Full Text] [Related]
58. Pax8 detection in well-differentiated pancreatic endocrine tumors: how reliable is it?
Moreno CM; Lorenzo PI; Delgado I; Cobo-Vuilleumier N; Gomez-Izquierdo L; Garcia-Carbonero R; Rojas A; Gauthier BR
Am J Surg Pathol; 2011 Dec; 35(12):1906-8. PubMed ID: 22067332
[No Abstract] [Full Text] [Related]
59. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.
Hoefler H; Denk H; Lackinger E; Helleis G; Polak JM; Heitz PU
Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):609-26. PubMed ID: 3092460
[TBL] [Abstract][Full Text] [Related]
60. A study of intermediate filaments (cytokeratin, vimentin, neurofilament) in two cases of Merkel cell tumor.
Dreno B; Mousset S; Stalder JF; Bureau B; Litoux P; Barrière H
J Cutan Pathol; 1985 Feb; 12(1):37-45. PubMed ID: 2579111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
